Tag: USPTO
-
Biotech, Pharma Dominate U.S. Academic Patents
In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total.
-
FDA Fast-Tracks Heart Failure Gene Therapy
A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration.
-
Survey: More Research Patents, Start-Ups in 2016
A survey of universities and other institutions shows the number of patent filings and new start-up companies resulting from federally-funded research climbed in 2016.
-
Patent Awarded for Live Bacterial Acne Treatment
A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria.
-
Patent Set for Peptide Nerve Damage Treatments
The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4.
-
Creative Ideas Mined with Crowdsourcing, Neural Nets
A computer science team developed a process that combines crowdsourcing and artificial intelligence to find analogies across disciplines to spark creative ideas.
-
Patent Awarded for Exosome Capture Process
A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses.
-
Broad Institute in Crispr Licensing Program
One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology.
-
Patent Awarded for COPD Dry Powder Inhaler Formula
A formulation for dry powder inhalers to treat respiratory diseases that its developers say delivers medication to the lungs more efficiently received a U.S. patent.
-
NIH Funds Seen Boosting Industry Patents
An analysis of grants issued by National Institutes of Health shows a large percentage of those grants, directly or indirectly, result in patented technologies in industry.